Abstract: A battery cell may include a housing, an electrode assembly, a current collector and a pressure relief structure. The end cover may be configured for covering the opening of the housing. The current collector may be configured for connecting the electrode assembly and the end cover. The pressure relief structure may be arranged on the end cover. A side of the end cover facing away from the electrode assembly may be provided with a concave, the concave may be configured for accommodating at least a portion of the pressure relief structure, a connecting part may be formed on the end cover in an area where the concave may be provided, the connecting part may be configured for being welded to the current collector to form a first welded part, and the pressure relief structure may cover the first welded part along a thickness direction of the end cover.

Abstract: A current collecting component for a battery cell having two output poles with opposite polarities for outputting electrical energy. The current collecting component includes two current collectors, an insulator, and a limiting structure. The two current collectors are arranged opposite each other along a width direction of the current collecting component and are configured to connect to the two output poles, respectively. The insulator is configured to connect the two current collectors and is located at least partially between the two current collectors in the width direction to insulate the two current collectors from each other. The limiting structure is configured to restrict the current collectors from leaving the insulator in the width direction.

Abstract: The present invention provides compounds of Formula I, pharmaceutical compositions comprising these compounds and methods of using these compounds to prevent or treat FXR-mediated or TGR5-mediated diseases or conditions.

Abstract: The present invention provides compounds represented by Formula I, or pharmaceutically acceptable salts, stereoisomers, solvates, hydrates or combination thereof, The invention also provides pharmaceutical compositions comprising these compounds and methods of using this compounds for treating FXR-mediated or TGR5-mediated diseases or conditions.

Abstract: The present disclosure relates to a spike event decision-making device, method, chip, and electronic device to eliminate inherent delays of an output spike event of the neuromorphic chip when reading decisions. The spike event decision-making device includes a first counting module configured to count a number of input spike events of the spiking neural network, a second counting module configured to count some or all of the output spike events of the spiking neural network; and a decision-making module configured to generate a decision-making result according to numbers of spike events fired by neurons in an output layer of the spiking neural network when the number counted by the first counting module reaches a first predetermined value, or when the total count counted by the second counting module reaches a second predetermined value.

Abstract: At least one processor identifies dependency relationships among libraries in a repository of libraries. Using the dependency relationships among libraries, at least one machine learning model can be created that predicts with a confidence value a dependency between a given library and a target library. An L layer tree-like graph can be created, using the dependency relationships among libraries and an application package. L can be configurable. Versions of the libraries to use can be determined by running the at least one machine learning model for each pair of nodes having a dependency relationship in the L layer tree-like graph, the at least one machine learning model identifying the dependency relationship with a confidence value, where pairs of nodes having largest confidence values are selected as the versions of the libraries to use in the application package.

Abstract: Mechanisms are provided for scheduling a workload in a cloud computing system. A cloud affinity factor (CAF) computer model is trained, via a machine learning process based on a training dataset comprising static characteristics of a workload binary for a workload, and dynamic characteristics corresponding to historical performance data for the workload, such that the trained CAF computer model predicts a performance classification for a given workload binary. The trained CAF computer model processes a new workload to generate a performance classification for the new workload. Cloud affinity factor(s) are generated based on the performance classification for the new workload. Node affinity and dispatch rule(s) are applied to the cloud affinity factor(s) to select one or more nodes of the cloud computing system to which to dispatch the workload. The workload is then scheduled on the selected one or more nodes.

Abstract: A method for recycling lead from spent lead-acid battery paste, relating to the technical field of hydrometallurgy. In the method, firstly a reducing agent, and a lead paste are added into a zinc chloride solution for leaching in a stirring mill to cause lead in the lead paste to enter the solution, a lead cementation is performed by using zinc in the leached solution, after the lead cementation, the electrolytic zinc is produced by controlling an electrodeposition on the zinc chloride solution for a short time, the reducing agent is zinc, lead or hydrogen peroxide, a part of the electrolytic zinc is returned as the reducing agent for leaching, the step of returning the electrolytic zinc as the reducing agent can be omitted when the lead or the hydrogen peroxide is used as the reducing agent.

Abstract: A method for recycling lead from spent lead-acid battery paste, relating to the technical field of hydrometallurgy. In the method, firstly a reducing agent, and a lead paste are added into a zinc chloride solution for leaching in a stirring mill to cause lead in the lead paste to enter the solution, a lead cementation is performed by using zinc in the leached solution, after the lead cementation, the electrolytic zinc is produced by controlling an electrodeposition on the zinc chloride solution for a short time, the reducing agent is zinc, lead or hydrogen peroxide, a part of the electrolytic zinc is returned as the reducing agent for leaching, the step of returning the electrolytic zinc as the reducing agent can be omitted when the lead or the hydrogen peroxide is used as the reducing agent.

Abstract: A method for preparing a PBAT laminated membrane composite material uses PBAT or a material with PBAT as the main component and other biodegradable plastic or superfine calcium carbonate in a mixture. The temperature of the mixture is increased by means of a lamination machine segment by segment, the material is heated slowly to a molten state, and the temperature of a rolling shaft is controlled by introducing cold water to the rolling shaft when the lamination machine conducts membrane lamination, so that the temperatures of rolling wheels and the laminated membrane are controlled.

Abstract: A method for preparing a PBAT laminated membrane composite material uses PBAT or a material with PBAT as the main component and other biodegradable plastic or superfine calcium carbonate in a mixture. The temperature of the mixture is increased by means of a lamination machine segment by segment, the material is heated slowly to a molten state, and the temperature of a rolling shaft is controlled by introducing cold water to the rolling shaft when the lamination machine conducts membrane lamination, so that the temperatures of rolling wheels and the laminated membrane are controlled.